← brief for 2026-11-04 · Slowing decline

Beyond Obesity: The Expanding Role of Glucagon-Like Peptide-1 Agonists in Chronic Kidney Disease, Pre- and Post-Renal Transplantation

Article No results yet Peer reviewed

Key takeaways

This review explains how a class of diabetes drugs called GLP-1 agonists may help people with kidney disease. It covers how these drugs work and their potential benefits. It is a summary of existing knowledge, not a new study with fresh results.

Who did this work

Shreya A Durve (Sri Ramachandra Institute of Higher Education and Research) · Satwik Kuppili · Vindhya Vasini Lella

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-11-03
https://doi.org/10.25259/gjms_9_2026